[Treatment of osteitis fibrosa with 1,25-dihydroxycholecalciferol in patients in treatment with periodic hemodialysis. Effects on the hematochemical and radiological picture].
D000328:Adult; D000368:Aged; D001842:Bone and Bones / Q000000981:diagnostic imaging; D002117:Calcitriol / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010002:Osteitis Fibrosa Cystica / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D011859:Radiography; D006435:Renal Dialysis
D010281:Parathyroid Hormone; D010710:Phosphates; D002117:Calcitriol; D002118:Calcium
Trattamento con 1,25-diidrossicolecalciferolo (1,25(OH)2D3) della osteite fibrosa in pazienti in trattamento emodialitico periodico. Effetti sul quadro ematochimico e radiologico.